Source: http://www.google.es/patents/US9468364
Timestamp: 2017-11-20 19:35:00
Document Index: 26824223

Matched Legal Cases: ['art.\n5', 'art 110', 'art 170', 'art 190', 'art 220', 'art 220', 'art 302', 'art 312', 'art 350', 'art 360', 'art 380', 'art 400', 'Application No. 08746822']

Patente US9468364 - Intravascular catheter with hood and image processing systems - Google Patentes
Image processing systems are described which utilize various methods and processing algorithms for enhancing or facilitating visual detection and/or sensing modalities for images captured in vivo by an intravascular visualization and treatment catheter. Such assemblies are configured to deliver energy,...http://www.google.es/patents/US9468364?utm_source=gb-gplus-sharePatente US9468364 - Intravascular catheter with hood and image processing systems
Número de publicación US9468364 B2
Número de solicitud US 12/618,306
También publicado como US20100130836, US20170020395
Número de publicación 12618306, 618306, US 9468364 B2, US 9468364B2, US-B2-9468364, US9468364 B2, US9468364B2
Inventores Zachary J. Malchano, Ruey-Feng Peh, Vahid Saadat, Ted J. Cooper, David Miller, Veerappan SWAMINATHAN
Citas de patentes (641), Otras citas (78), Clasificaciones (21), Eventos legales (3)
Intravascular catheter with hood and image processing systems
US 9468364 B2
Image processing systems are described which utilize various methods and processing algorithms for enhancing or facilitating visual detection and/or sensing modalities for images captured in vivo by an intravascular visualization and treatment catheter. Such assemblies are configured to deliver energy, such as RF ablation, to an underlying target tissue for treatment in a controlled manner while directly visualizing the tissue during the ablation process.
1. A method of imaging a tissue region which is under motion, comprising:
visualizing the tissue region within a body via an intravascular imaging catheter by viewing the tissue region through an open hood in contact with the tissue region and where the hood is purged of blood with a fluid, the visualizing resulting in a plurality of visual images of the tissue region;
recording electrical activity of the tissue region while visualizing the tissue region, the recording performed with a computer;
receiving a selection of a recurring portion of an event which repeats at least periodically in the electrical activity, the receiving performed with the computer;
selecting a visual image from the plurality of visual images of the tissue region captured by the intravascular imaging catheter during an instance of the recurring portion of the event, the visual image corresponding to the recurring portion of the event, the selecting performed with the computer;
capturing one or more additional visual images gated by the event over a period of time;
registering the selected visual image with one or more ablation parameters associated with an ablation process performed on the tissue region, the registering performed with the computer; and
displaying the selected visual image with the one or more registered ablation parameters, the displaying performed with the computer.
2. The method of claim 1 further comprising displaying the visual image corresponding to the event.
3. The method of claim 1 further comprising selecting a plurality of visual images each captured during the event over a plurality of repeated events.
4. The method of claim 1, wherein the visualizing comprises visualizing cardiac tissue within a chamber of a heart.
5. The method of claim 1, wherein the visualizing further comprises recording the visual images of the tissue region simultaneously while recording the electrical activity.
6. The method of claim 1, wherein the recording comprises recording electrocardiogram data of the tissue region.
7. The method of claim 1, wherein the selecting an event comprises selecting an electrical event during a QRS Complex of the tissue region.
8. The method of claim 1 wherein the one or more ablation parameters is an operational parameter of an ablation catheter and is selected based upon a detected thickness of the tissue.
This application claims the benefit of priority to U.S. Prov. Pat. App. 61/114,834 filed Nov. 14, 2008, which is incorporated herein by reference in its entirety.
In utilizing the devices and systems to access and image tissue, particular tissue regions within the body to be visualized and/or treated may undergo occasional or constant movement in vivo. For instance, organs such as the lungs constantly expand and contract while the patient undergoes respiration and other organs such as the heart constantly contract to pump blood through the body. Because of this tissue movement, acquiring a tissue image and/or other physiologic data taken at a first instance may present a condition which is inconsistent with the tissue image and/or physiologic data taken at a second instance. Accordingly, being able to acquire images and/or physiologic data of a particular tissue region at a first point during tissue movement and at additional points during subsequent tissue movements taken consistently when the tissue is similarly situated may present a more accurate representation of the condition for evaluation of the tissue region being examined and/or treated. To accurately assess and/or treat a particular tissue region despite this movement of tissue, e.g., a tissue region located within an atrial chamber within the beating heart, methods may be utilized to minimize the effect of this movement on obtained data.
One method may involve gating the acquisition of the tissue images and/or corresponding data by utilizing a reference signal produced by the body for coordinating the corresponding acquisition of information. For gated acquisition of information, such as the captured visual images of the tissue and/or corresponding physiologic parameters, the acquisition of the information may be triggered by a sensed event, e.g., the QRS complex recorded from a single heartbeat of the electrocardiogram (ECG) which corresponds to a depolarization of the right and left ventricles. Once a triggering event is identified, the system may acquire information at a specific interval and/or for a specific duration based upon that predetermined triggering event.
Although this and other examples describe the gated acquisition of information based upon the patient's ECG measurements, other gated acquisition events may also be utilized herein. For example, gated acquisition may also be utilized for obtaining images and/or other data based on chest-wall motion for respiratory-gated acquisition of data.
Another method for may involve retrospective gating of the data where information, such as visual images and/or other physiologic data, may be acquired continuously from the tissue region. This allows for the capturing of information over several cycles of the organ or tissue region of interest. By calculating or determining a timing delay within the captured data, the information can be reconstructed at one or more specified points over many heart beats relative to a predetermined reference or triggering signal. This may allow for a “snapshot” of the heart to be reconstructed at a specific phase within the cardiac cycle with the information for this “snapshot” acquired over several beating cycles which may or may not have occurred at regular intervals.
Ablation treatment of various tissue regions may also be optimized by determining the thickness of the tissue region to be treated and adjusting the ablation parameters accordingly based upon this thickness. Aside from tissue thickness and ablation parameters, it may be also useful to monitor the temperature and/or electrical potential of the tissue surface during the ablative process.
Aside from or in addition to the different modalities for monitoring tissue parameters, visually assessing the tissue region undergoing ablation may present difficulties in distinguishing between different regions of the tissue due to limitations in the imaging sensors or equipment. One method for improving the visual images of the imaged tissue for assessment by the user may include adjusting the contrast of the captured images. Contrast allows for different tissue regions to be distinguished visually from one another within an image or video. Digital imaging systems such as CMOS image sensors or CCD camera systems have light sensitivities which vary with the wavelength of light. Thus, altering the chromaticity or color of illumination used during imaging could emphasize or de-emphasize certain colors within the imaged field or the change in illumination color composition could target the sensitivity of the image sensor.
With the detection of multiple lesions along a tissue region, the unique shape of each lesion may be used to determine the “address” of that particular lesion. An edge finding, texture classification, or morphology algorithm may be used to determine the outline, surface pattern, or shape of the lesion from the visual information provided by the visualization device. This information and/or an image depicting the ablation lesion is then constructed into an array and tagged with the appropriate data such as the RF power and the length of time ablation took place to create the particular lesion. Alternatively, lesion identification may be accomplished via the usage of color comparison algorithms and/or biological markers on the lesions among other identifiers. This information may be particularly useful for re-identification, comparison and mapping of all lesions on the tissue surface.
When providing real-time visual images for the purposes of tissue diagnosis or treatment, it may be useful to overlay relevant information to aid the physician during diagnosis and/or treatment. Any number of physiologic or treatment parameters may be overlaid directly upon the monitor for display to the user to facilitate assessment or treatment, e.g., for estimating the depth of the lesion formed. In various examples, treatment information (e.g., positional information, applied power levels, time of ablation treatment, etc.) may be superimposed on the image of lesion or any other additional information (e.g., applied voltage, tissue thickness, etc.) may also be displayed upon the monitor for display to the user.
Yet another example of an informational overlay which may facilitate tissue treatment assessment may incorporate the distance of a tissue region to be treated (or undergoing treatment) to a predetermined anatomical object or location. It is also possible to overlay information relating to particular metrics on the monitor during visualization or ablation. Such overlays may be utilized to determine, e.g., the surface size of the lesion precisely to facilitate physician assessment of lesion size. It may also be used to accurately measure anatomical features in the body.
Aside from measuring anatomical features, another feature which physicians may utilize with the captured visual images of tissue may also include the monitoring of changes in color of a lesion formed over time. Tissue color may be used as a good indicator of the stage of completion of the lesion forming process as normal, unablated myocardial tissue is characteristically pink or red in color. Having these images simultaneously displayed may provide contextual information to the user in determining whether sufficient ablation had occurred in the tissue being treated.
Additionally and/or alternatively, a processor may control the flow of the purging fluid which may also be used to conduct a current to the tissue to be treated. It is generally desirable to deliver the lowest amount of saline to the patient through the hood as an excessive flow of saline may cause the balance of electrolytes in the body to fluctuate potentially resulting in hyponatremia. Yet another parameter utilizing the captured visual images during tissue ablation may include the detection of bubbles during ablation. The formation of bubbles may be visible on the monitor near or at the edges of the visual field and these bubbles may be generally indicative of high rates of heating, over-blanching of tissue, or a potential steam popping. The visual image may be processed by a processor to find locations of any “hotspots”, i.e., areas of high reflection, which may be indicative of the presence of bubbles.
In yet another example for processing captured visual images of tissue regions, the region being visualized may move continually making it difficult to observe the tissue or to perform any procedures upon the tissue. Such movement can be monitored visually by several methods such that the user is able to determine an appropriate time to begin a procedure. With the distance of hood movement known, a procedure may be initiated and/or stopped appropriate each time the hood is expected to move such that treatment may be synchronized according to hood and tissue movement.
In yet another example of utilizing the captured images, bubbles may be visible in the field of view and thus alert the user that the hood positioning along the tissue may require readjustment.
FIG. 6 shows a perspective assembly view of the steerable section of a catheter having a distal section with connected links configured to allow for multi-directional articulation, e.g., four-way articulation, and a proximal section with connected links configured to allow for articulation within a single plane, e.g., one-way articulation.
FIG. 7 illustrates an assembly view of a visualization and treatment system advanced intravascularly into a patient's heart for diagnosis and/or treatment.
FIG. 8A shows a flowchart illustrating one example for synchronizing visual images of tissue with electrocardiogram data to capture images of consistent regions of tissue.
FIG. 8B shows an example of how visual images of tissue may be captured at coordinated intervals.
FIGS. 9A and 9B show, respectively, a schematic illustration and representative graph of a tissue region undergoing ablation and the temperature differential resulting between the tissue surface and underlying tissue region.
FIG. 9C shows a flowchart illustrating one example for determining suitable ablation parameters for a given thickness of tissue.
FIG. 10 shows a flowchart illustrating one method for monitoring tissue temperature during ablation treatment.
FIG. 11 shows a flowchart illustrating one method for improving a contrast level of visualized tissue to improve the image clarity.
FIGS. 12A and 12B show an illustrative example of a map of lesions created over a tissue region and a generated table of the corresponding parameters for each lesion.
FIGS. 13A and 13B illustrate an example of a first lesion created along a tissue region and the corresponding visual image through the hood and generated map of lesion location.
FIGS. 14A and 14B illustrate another example of a second lesion and the corresponding visual image and generated map indicating relative lesion location.
FIGS. 15A and 15B illustrate another example of a third lesion and the corresponding visual image and generated map again indicating relative lesion location.
FIG. 16 illustrates a visualized image of tissue with an example of a generated informational overlay imposed upon or in proximity to the visualized image indicating certain parameters, e.g., lesion location, power levels, ablation times, etc.
FIGS. 17A and 17B illustrate examples of a visualized region of tissue having its measured electrical potential overlaid upon the image prior to and during or after ablation.
FIGS. 18A and 18B illustrate examples of a visualized region of tissue having its measured temperature overlaid upon the image prior to and during or after ablation.
FIG. 19 shows an example of a visualized image of region with specified informational data, such as distance from a lesion to a specified anatomical feature, overlaid upon the image.
FIG. 20 shows an example of a visualized region of tissue with specified information data, such as lesion length, overlaid upon the image.
FIGS. 21A and 21B show examples of a visualized region of tissue which is treated or has been treated by formation of a lesion while images the same region is captured during the ablation process for comparison.
FIG. 22 shows an example for visually monitoring a degree of blanching of a tissue region undergoing ablation treatment.
FIG. 23 shows an example for monitoring and/or controlling a flow of saline before and/or during ablation treatment.
FIG. 24 shows an example for visually monitoring bubble formation on tissue during ablation.
FIGS. 25A and 25B illustrate an example of inadvertent hood movement over a tissue region and the resulting change in the visual field.
FIGS. 26A and 26B illustrate an example of incomplete hood apposition against the tissue surface and the resulting formation of bubbles along one side of the visual field.
Turning now to the perspective assembly view of FIG. 6, one variation of an articulatable deployment catheter 50 is shown which comprises a distal steerable section 52 and a proximal steerable section 54 located proximally of the distal steerable section 52. Further details of the deployment catheter 50 which may be used herein may be seen in further detail in U.S. patent application Ser. No. 12/108,812 filed Apr. 24, 2008 (U.S. Pat. Pub. No. 2008/0275300 A1), which is incorporated herein by reference in its entirety. An intervening link 56 may couple the sections 52, 54 to one another and provide a terminal link to which one or more pull wires may be attached in controlling one or both sections. The distal steerable section 52 may utilize individual links 66 which allow for the section 52 to be articulated in a variety of different directions and angles, e.g., four-way steering, to enable omni-direction articulation. The individual links 66 may accordingly utilize a body member 68 having a pair of yoke members 70 positioned opposite to one another and extending distally from the body member 68 and each defining an opening. A pair of pins 72 may each extend radially in opposing directions from body member 68 and in a perpendicular plane relative to a plane defined by the yoke members 70. The pins 72 of each link 66 may be pivotably received by the yoke members 70 of an adjacent link 66 such that the pins 72 and yoke members 70 are joined in an alternating manner. This alternating connection allows for the serially aligned links 66 to be articulated omni-directionally.
In utilizing the catheter 50 or other suitable catheter system, FIG. 7 shows an illustrative assembly of how a visualization catheter system may be configured and advanced intravascularly within a patient. Further details of the system which may be used herein may be seen in further detail in U.S. patent application Ser. No. 12/323,281 filed Nov. 25, 2008 (U.S. Pat. Pub. No. 2009/0143640 A1), which is incorporated herein by reference in its entirety.
FIG. 7 illustrates a perspective assembly view of an endoscope 108 introduced within seal 94 and deployment catheter 88. Hood 12 can be first collapsed by hood retraction control 98 while saline is purged through hood 12 to ensure no bubbles are trapped inside hood 12. Catheter 88 may be advanced within introducer sheath 106 for deployment within the patient body. Additionally, introducer sheath 106 may further include a fluid irrigation port 104 extending from sheath 106 for coupling to a fluid reservoir or for providing access to other instruments into the patient body. The variation shown also illustrates an example where an additional endoscope handle interface may be attached to hub 100 for facilitating coupling and de-coupling to endoscope handle 102.
Hood 12 and deployment catheter 88 may be advanced through introducer sheath 106 into the patient's vasculature, e.g., through the inferior vena cava IVC and transseptally into the left atrium LA of the patient's heart H, where tissue regions may be treated, such as lesion creation around the ostia of the pulmonary veins for treatment of atrial fibrillation. Once hood 12 has been advanced into the left atrium LA, hood 12 may be deployed to expand for visualization and tissue treatment. Hood 12 may be purged via saline fluid from reservoir 82 introduced through port 96 while an electrode assembly along hood 12 may be utilized to detect, e.g., ECG signals 90, or to ablate tissue via generator 80. These electrical signals may be detected and/or delivered via the electrode assembly which may be electrically coupled through catheter 88 to a processor and/or video display, e.g., electrocardiogram (ECG) display, via junction 92, which may also be electrically coupled to generator 80 for providing power, e.g., RF energy, to the electrode assembly. The underlying tissue may be visualized via the endoscope imaging assembly which may in turn be coupled to video processor assembly 84 which may capture and process the detected images within hood 12 for display upon monitor 86. Alternatively, hood 12 may be purged via fluid introduced through a fluid lumen defined through the endoscope itself.
The working channel of the endoscope and/or irrigation port can also be used to introduce guidewires, needles (such as transseptal or biologics delivery needles), dilators, ablation catheters (such as RF, cryo, ultrasound, laser and microwave), temperature monitoring probes, PFO closure devices, LAA closure implants, coronary artery stents, or other implantable devices or tools for performing diagnosis and/or treatment of the imaged target tissue. These lumens can also be used for the suction and/or evacuation of blood clots and/or any tissue debris as well as for the injection of contrast media for fluoroscopic imaging.
Generally, when two-dimensional images of a moving organ, such as the heart, are captured the images are built up over time in synchronization with respect to the movement of the organ. For example, CT images of the heart may be captured in synchronization with a sensed ECG signal such that all the CT image slices are generated at the same point during the heart cycle. In the absence of such synchronization, the three-dimensional images may be blurred rendering them unsuitable for analysis. Additionally and/or alternatively, images of the organs may also be synchronized with the respiratory cycle, as previously mentioned.
When anatomical features, electro-anatomical maps, or any other real-time data is to be registered against real-time visual images of the heart or any other moving organ, a determination of which cycle the image was acquired may be used to achieve proper registration between the data and the corresponding image. Generally, one or more visual images may be collected simultaneously with the sensed ECG data. An example for synchronizing data, in this case ECG data, with real-time visual images is illustrated in the flowchart 110, as shown in FIG. 8A. The hood 12 may be advanced intravascularly, e.g., into a heart chamber such as the left atrial chamber, where it may be presented against a tissue region of interest moving as the heart continues to beat. The hood 12 may be cleared, as previously described, and one or more images of the underlying tissue may be acquired 112. These one or more images may be buffered 114 and multiple images may be acquired 116 until sufficient images are captured.
While the visual images are captured, one or more sensors located along the hood 12 or separately upon the patient may be used to simultaneously detect and record ECG data 118. In the event that a sufficient number of images have been captured, a gating point may be selected 120 such as during an R wave of the QRS Complex, although any number of other physiologic triggering points may be utilized. With the gating point determined, a controller or processor may select the appropriate visual image 122 which was captured correspondingly and transmit the visual image data 124 for comparison. The controller or processor may then adjust the gating point 126, if necessary, in which case the gating point may be appropriately adjusted 134 by selecting another appropriate image. Should the gating point be adjusted to a different gating point, a new set of corresponding visual images may be displayed. Such synchronization may allow for visual analysis of the tissue that is imaged as the impact on the image quality due to the movement of the tissue may be greatly reduced (for example, due to the expansion and contraction of the heart). While the visual images are selected and transmitted, the recorded ECG data may be extracted 128 and the data may be registered with the corresponding visual image 130. The final extracted image with the corresponding ECG data may then be displayed as a composite image 132 to the user.
As illustrated in the example of FIG. 8B, a detected and recorded ECG measurement 140 of a patient is shown and displayed over several cycles of the heart beating. While the ECG measurement 140 was recorded, the visual images of the tissue region of interest were simultaneously captured as well. In utilizing the R wave of the QRS Complex, in this example, as the triggering or gating point, the visual images of the tissue region captured at those corresponding times may be extracted and registered corresponding to each gating point. The image at each gating point may then be displayed to the user as a composite image, as shown. Thus, the first gating point 142 shown on the ECG measurement 140 may have a first corresponding image 150 displayed accordingly and the second gating point 144 may have a second corresponding image 152 displayed accordingly as well. Likewise, third gating point 146 may have third corresponding image 154 displayed while fourth gating point 148 may have fourth corresponding image 156 displayed, and so on. In this manner, the visualized tissue region may be compared between captured images to provide a more accurate representation of the tissue in any particular state.
Moreover, cardiac-gating of information allows for piece-wise data acquisition over multiple heart beats to create a global view of the heart at a single phase within the cardiac cycle. For example, within the left ventricle, the end-systolic phase of the cardiac cycle represents the maximum contraction of the ventricle. Therefore, the ventricular cavity defines its relative smallest volume at this phase of the cardiac cycle. Likewise, the end-diastolic phase of the cardiac cycle represents the end of the filling period of the left ventricle with blood. The ventricle is at its maximum or near-maximum volume at this phase.
Throughout each cardiac cycle, a point on the endocardial surface may be displaced in three-dimensional space between these two phases of the cardiac cycle. To create a three-dimensional map of the endocardial surface during end-diastole, individual mapping points may include the relative position (e.g., X, Y, Z coordinates) to be consistently captured at the point during the cardiac cycle relative to the reference or gating signal, such as the ECG signal. These methods could also be applied to the captured visualization information. In order to capture an image at the same point in the cardiac cycle, a global reference such as the ECG signal may be used. Based on timing data relative to a specific event such as the QRS Complex on the ECG recording, the image could be correspondingly registered by calculating the timing delays within the system for data acquisition and processing. These delays could shift the two data streams relative to one another.
In treating a tissue region, e.g., via application of energy such as RF energy to create lesions, one physiologic characteristic which is usually not readily available to physicians is the thickness of the tissue at a desired lesion location. It may be generally useful to know the thickness of the tissue in facilitating lesion formation by applying an appropriate level of energy to prevent excessive lesion formation (e.g., lesions which are larger and/or deeper than desired) in order to prevent damage to surrounding tissue or anatomy. Information on the tissue thickness may also be useful to the physician so that the optimal parameters for ablation may be determined with respect to the speed of the ablation formation to safely reduce procedural time.
One of the difficulties in determining appropriate ablation treatment parameters through the hood 12 may be due to the temperature gradient formed through the tissue thickness during ablation treatment. For example, FIG. 9A illustrates an example of hood 12 placed against a tissue region T to be ablated. As energy is conducted through hood 12 and into the underlying tissue, a temperature differential is formed between the tissue surface T1 and a region of underlying tissue T2. As heat is conducted from the tissue surface T1 down through the tissue region T, tissue surface T1 may undergo ablation first as its temperature rises quickly during ablation treatment, as indicated by curve 162, relative to the temperature of the underlying tissue T2 which rises slowly over time, as indicated by curve 164, shown in the ablation time versus temperature graph 160 of FIG. 9B.
One example for determining the thickness of a tissue region to be treated and for selecting ablation parameters based on this thickness is illustrated in the flowchart 170 of FIG. 9C. With the tissue region to be treated identified visually (or through other modalities) 172, the tissue thickness may be detected 174 utilizing, e.g., hood 12 having one or more ultrasonic transducers positioned upon hood 12 or its distal membrane in contact with the underlying tissue. For example, prior to the initiation of tissue ablation, the one or more transducers may be placed against the tissue surface to be treated and ultrasonic signals may be emitted into the tissue. The emitted signals may be reflected by any underlying obstructions or tissue interfaces such that the return signals received by the transducer or receiver may be automatically processed by a processor to analyze the return signals for peaks of the ultrasonic waves received and the time intervals between them to determine a thickness of the underlying tissue. Examples of ultrasound use with hood 12 are shown and described in greater detail in U.S. patent application Ser. No. 12/118,439 filed May 9, 2008 (U.S. Pat. Pub. 2009/0030412 A1), which is incorporated herein by reference in its entirety. Alternatively, tissue thickness may also be determined by, e.g., sensor triangulation techniques, trans-esophageal echocardiography or any other methods.
A nominal tissue thickness may be programmed into a processor by the user to set a threshold tissue thickness for safely performing tissue ablation. The detected tissue thickness may then be compared against this nominal thickness threshold 176. In the event that the detected thickness exceeds this threshold tissue thickness, the controller may automatically determine the appropriate ablation parameters suitable for this detected thickness 178 such as, power levels (e.g., Watts), flow rate of the purging/conductive fluid through the hood (e.g., cc/min), ablation treatment times (e.g., sec), etc. (which may be available on a table of tissue depth versus power, flow rate, ablation duration, etc.). This determination may be performed automatically by the system or by the user and ablation may be started 180 either automatically or initiated by the user. In the event that the detected tissue thickness fails to meet the threshold tissue thickness, the system may alert the user 182 who may then re-measure the tissue thickness 184. If the re-measured tissue thickness exceeds the nominal tissue thickness, ablation may proceed, as previously described, or the operator may determine the ablation parameters manually 186 and then initiate ablation 180.
Additional examples of devices and methods which may be utilized with the systems described herein are further shown in U.S. Pat. Pub. 2007/0106146 A1, which is incorporated herein by reference in its entirety.
Aside from tissue thickness and ablation parameters, it may be also useful to monitor the temperature of the tissue surface during the ablative process. Ablation of tissue is typically performed such that it causes irreversible tissue damage to selected regions of tissue. The temperature at which irreversible tissue damage typically occurs is around 53° C. depending on the tissue thickness. Excessively high temperatures may give rise to the possibility of bubble formation on the tissue (which may pop as steam) or tissue charring. Steam pops, which may burst with an audible popping sound, may disrupt the myocardium and cause perforations on the tissue surface potentially leading to complications, such as cardiac tamponade, which may cause the heart to pump decreasing amount of blood. Charring of tissue may also allow thrombus formation which may embolize and potentially lead to stroke, ischemia, and/or myocardial infarction among other things.
One example for monitoring tissue temperatures prior to and/or during tissue ablation is illustrated in the flowchart 190 of FIG. 10. Once the targeted tissue region is identified 192 utilizing the devices and methods described above, the tissue temperature (surface and/or subsurface tissue temperatures) may be initially measured 194 utilizing any number of temperature measurement devices. For example, temperature sensors may be positioned along the hood 12 and/or distal membrane of the hood in contact against the tissue surface. Other sensors may include, e.g., thermocouples, thermistors, fluoro-optic temperature sensors, thermochromic markers under direct visualization through the hood 12, etc. Thermochromic markers may be embedded within the distal membrane which may be pressed against the tissue region. Changes in the marker colors which are indicative of the tissue temperature changes may be monitored through hood 12 via the imager or via an automated vision sensing system. Further examples of tissue temperature sensors and methods of their use are described in further detail in U.S. patent application Ser. No. 12/118,439, which is incorporated herein by reference above.
Additionally, needle probes or similar devices may be inserted into the tissue region to be treated to provide a measurement of the sub-surface tissue temperature. Further examples of sub-surface measurement systems and methods of their use which may be utilized with the devices and methods described herein are shown in further detail in U.S. patent application Ser. No. 11/775,837 filed Jul. 10, 2007 (U.S. Pat. Pub. 2008/0009747 A1), which is incorporated herein by reference in its entirety.
With the tissue surface and/or sub-surface temperatures measured, upper THigh and/or lower TLow limits for the allowed temperature range are set 196 to ensure adequate power delivery for therapy yet prevent unwanted complications due to excessive (or inadequate) energy delivery. The tissue may then be ablated 198 while the tissue temperature (surface and/or sub-surface) is monitored. So long as the monitored tissue temperature remains above the preset lower TLow temperature limit 200, ablation may continue 202 unabated. In the event that the tissue temperature falls below the lower TLow temperature limit, an audible or visible indicator may notify the user and/or a controller may pause the ablation 208. Attention by the user may allow for adjustment of the ablation treatment and/or preset temperature limits.
During ablation treatment, so long as the upper THigh temperature limit is not exceeded 204, ablation may continue until the procedure is completed 210 and ablation treatment may be stopped 212. However, in the event that the monitored tissue temperature exceeds the upper THigh temperature limit 204, an audible or visible indicator may notify the user and/or a controller may pause the ablation 206. Attention by the user may allow for adjustment of the ablation treatment and/or preset temperature limits 210 so either allow for continued ablation treatment 202 or cessation of ablation 212.
FIG. 11 shows an example for improving image contrast prior to and/or during tissue ablation in flowchart 220. Such a method may be utilized while visually observing tissue ablation through hood 12 via the imager to improve contrast and differentiation between regions of, e.g., normal myocardial tissue and regions where ablation lesions have been created for the treatment of cardiac arrhythmias such as atrial fibrillation. Generally, images acquired from the field of view through hood 12 may have their contrast levels and other relevant characteristics determined and then compared to previously stored data. If additional contrast is needed or desired, a processor may be used to increment various illumination color channels (such as the brightness of different color LED light sources which combine to provide the illumination). Following each incremental adjustment, the processor may re-evaluate the contrast levels and continue to adjust the color balance of the illumination source. If additional changes in contrast are determined to be unnecessary or differences in contrast are nominal or eliminated between comparisons, the processor may evaluate the output image with respect to the range limits of this system.
As shown in flowchart 220, as the images of the tissue region of interest are captured, this may be done while the system begins in a default mode 222. During this image acquisition of the underlying tissue region defined within the field of view of the hood, the RGB (red, green, blue) values of the images may be acquired 224 and determined by a processor and then optionally converted to an HSV (hue, saturation, value) color model (or other color space) 226 to more accurately describe the perceptual color relationships. The newly obtained images with their RGB or HSV values may then be compared and contrasted to a previously obtained frame or stored frame 228 via the processor. In the event that the contrast levels are increased 230 in view of the comparison, the RGB values in the light source illuminating the tissue region may be increased incrementally and sequentially 232 by the processor and the entire process repeated until the contrast levels are equivalent between previously obtained images and newly obtained images 230. Once the contrast levels have been equalized, the RGB or HSV values may be compared against predetermined range limits 234 by the processor.
A comparison of the images against the range limits may yield RGB values which exceed these limits 236, in which case the images and/or range limits may be reset and the processor may perform a diagnostic test on the system 238 and an indication or warning may alert 240 the user. Otherwise, if the images against the range limits yield RGB values which are within the limits, then the contrast levels and light settings may be recorded 242 and the RGB light source may be set to these values 244 and the visualization assessment or procedure may proceed 246.
With the imaging contrast levels appropriately adjusted for visualizing the tissue region, visualization and/or treatment of one or more tissue regions may be performed. In the event that multiple lesions are to be formed over a tissue region, each of these lesions may necessitate ablation parameters which vary from one another to optimally treat the tissue region 250 which can vary physiologically depending upon which region is treated. Accordingly, the user may automatically track the parameters and locations which may be unique for each of the lesions formed over tissue region 250, as shown in FIG. 12A. The table in FIG. 12B shows an example of how a processor in communication with the visualization and/or treatment device may catalogue and identify each formed lesion utilizing visual information captured from the field of view through the hood 12.
In one variation, the unique shape of each lesion may be used to determine the “address” of that particular lesion. An edge finding, texture classification, or morphology algorithm may be used to determine the outline, surface pattern, or shape of the lesion from the visual information provided by the visualization device. This information and/or an image depicting the ablation lesion is then constructed into an array and tagged with the appropriate data such as the RF power and the length of time ablation took place to create the particular lesion. Accordingly, first lesion 252 may be identified by its unique shape and/or relative location and its corresponding power level and ablation time may be identified on the array. Likewise, each subsequent lesion, e.g., second lesion 254, third lesion 256, fourth lesion 258, fifth lesion 260, etc. may have its own power level and ablation time associated accordingly.
Alternatively, lesion identification may be accomplished via the usage of color comparison algorithms and/or biological markers on the lesions among other identifiers. This information may be particularly useful for re-identification, comparison and mapping of all lesions on the tissue surface 250. If catheter position information is available, this information may be combined with the data of the array of FIG. 12B to automatically map out the ablation lesions relative to their position within the heart.
When multiple areas along the tissue region 270 have lesions formed on them, a navigational mini-map may be utilized which allows the physician to view, track and/or map the multiple lesions that are formed on the tissue surface during the ablative treatment. In using the lesion address array previously described, lesions may be detected and/or their relative location to one another may be determined by various methods, such as measuring optical flow as the hood of the catheter moves from one site to another. This information may be then displayed on a map on the monitor 278. For example, a first lesion 272 may be seen on the tissue region 270 in FIG. 13A with the lesion 272 as seen through the hood 12 in the corresponding field of view 282. The location of the first lesion 272 may accordingly be registered and illustrated, e.g., on image 280 of display 278, as shown in FIG. 13B.
A directional movement indicator may be superimposed to point in a first direction 284 on the monitor 278 to indicate a direction in which the catheter hood 12 is moving (or is to be moved) relative to the tissue surface 270 and/or other lesions. Thus, FIG. 14A shows the position of a second lesion 274 which has been formed (or is to be formed) on the tissue surface 270. Image 280 may illustrate the position of the second lesion 274 relative to the first lesion 272 and the field of view 282 may show the visual image of the lesion 274 itself, as shown in FIG. 14B. The directional indicator may indicate a second direction 284′ in which the hood 12 is moving (or is to be moved) to reach the location of the third lesion 276 which is either formed or to be formed. Likewise, FIG. 15A shows the position of a third lesion 276 relative to the first 272 and second 274 lesions while image 280 may reflect the relative positioning on monitor 278. Third lesion 276 may be shown in the field of view 282 while the directional indicator may point to yet another direction 284″ in which hood 12 may be moved for lesion visualization and/or formation, as shown in FIG. 15B.
When providing real-time visual images for the purposes of tissue diagnosis or treatment, it may be useful to overlay relevant information to aid the physician during diagnosis and/or treatment. One such example of an overlay is shown in the monitor 278 of FIG. 16 which illustratively shows the field of view 282 as seen through hood 12 with lesion 290 previously or recently formed. Any number of physiologic or treatment parameters may be overlaid directly upon the monitor 278 for display to the user to facilitate assessment or treatment, e.g., for estimating the depth of the lesion formed. In this example, treatment information 292 (e.g., positional information, applied power levels, time of ablation treatment, etc.) may be superimposed on the image of lesion 290. Any other additional information 294 (e.g., applied voltage, tissue thickness, etc.) may also be displayed upon monitor 278 for display to the user.
Another overlay that may be applied is related to visually representing the electric potential of the tissue surface. Electrodes positioned along the hood may be used to measure the electrical potential (such as the bipolar voltage amplitude or monopolar voltage amplitude relative to a reference catheter or Wilson central terminal) of points on a tissue surface. Further examples of electrodes positioned along the hood and/or distal membrane which may be utilized herein are described in detail in U.S. patent application Ser. No. 12/118,439, which is incorporated herein by reference above.
FIG. 17A shows a monitor view of measured gradient of electric potential 300 of the tissue overlaid upon the visualized tissue region seen in the field of view 282 through hood 12. An electrical potential indication chart 302 may be seen also on monitor 278 to indicate the level of detected electrical potential for reference by the user. During lesion formation, as shown in FIG. 17B, the measured electric potential at the region of the lesion 304 may be monitored and overlaid atop the visualized lesion. A threshold value of electrical potential may be optionally preset by the user such that if the measured electrical potential of the lesion is reduced during ablation, e.g., <0.5 mV bipolar voltage, then an indicator may alert the user that the lesion has been successfully electrically isolated from the surrounding tissue. This may facilitate physician assessment as to when lesion formation is complete.
Additionally and/or alternatively, other information may be overlaid upon monitor 278 for facilitate physician assessment. For example, FIG. 18A illustrates an example where the temperature gradient 310 of the visualized tissue may be measured and superimposed upon the visualized tissue utilizing temperature sensors, as described in further detail in U.S. patent application Ser. No. 12/118,439, which is incorporated herein by reference above. A temperature indication chart 312 may be shown along the monitor 278 for reference by the user. As previously described, ablation may be controlled such that the tissue remains within prescribed temperature limits. Overlaying the temperature information of the lesion 314 as it is being formed may assist the physician, e.g., in assessing whether to terminate the ablation should a localized hot spot develop on the tissue surface, as shown in FIG. 18B.
Yet another example of an informational overlay which may facilitate tissue treatment assessment may incorporate the distance of a tissue region to be treated (or undergoing treatment) to a predetermined anatomical object or location. For example, ablation of heart tissue typically occurs near the location of the esophagus, which lies very close to and often touches the outer wall of the left atrium, within the body. The heat from the ablation procedure may penetrate through the tissue of the left atrium and reach the esophagus. Uncontrolled ablation may thus present a risk as lesions may be formed which extend towards or in proximity to the esophagus thus potentially damaging the esophageal tissue. Such damage is extremely dangerous as the damaged esophagus may become infected and lead to an esophageal fistula (hole in the esophagus). Over time, this may lead to an infection spreading into the heart wall which carries a relatively high mortality rate. To avoid damage to the esophagus (or any other object or anatomical structure in proximity to the ablated tissue region), mapping catheters and other imaging methods such as use of swallowed contrast agents or probes to indicate either the pre-operative or real-time position of the esophagus may be used. To that end, some physicians have used standard mapping catheters to record the pre-procedure location of the esophagus. However, such a pre-procedure location determination fails to account for the mobile nature of the esophagus. The esophagus generally does not remain stationary. Rather, the esophagus often moves back and forth thereby positioning itself in different locations relative to the heart wall. As such, the esophagus may change its location during a catheter-based endocardial procedure. The pre-procedure determination fails to account for this movement. Accordingly, displaying information in real-time such as the proximity of the ablation catheter to the probe on the monitor 278 may facilitate such treatments, as shown in FIG. 19, which shows lesion 320 and distance information to a preselected object 322, such as the esophagus. Moreover, a directional indicator to the object 324 may also be imposed on monitor 278 to indicate to the user the relative direction to the object.
Non-limiting examples of suitable analysis techniques for determining distance for use with the system, devices, and methods described herein may include impedance measurement, pacing signal amplitude measurement, use of magnetic fields, use of Hall effect sensors, inductance measurement, capacitance measurement, etc. Thus, a physician may continuously monitor throughout an entire mapping and/or ablation procedure the position of the object, such as the esophagus, relative to the device in use in the heart. This continuous, real time monitoring of the location of the esophagus may further accounts for the movement of the esophagus to decrease the risk of damage to the esophagus. Additional examples which may be utilized herein are further described in detail in U.S. Pat. Pub. 2007/0106287 A1, which is incorporated herein by reference in its entirety.
It is also possible to overlay information relating to particular metrics on the monitor 278 during visualization or ablation. For example, FIG. 20 illustrates an example of how distances 332 between two selected points may be measured directly on the monitor 278 to provide metric information 330 such as the length of a particular lesion. Such overlays may be utilized to determine, e.g., the surface size of the lesion precisely to facilitate physician assessment of lesion size. It may also be used to accurately measure anatomical features in the body. Typically, a reticule of a known distance may be included within the field of view which would allow for calibration of the measurement to a know distance. The accuracy of this measurement would be highest for objects that are in the same plane as the calibration distance. Further examples of measuring tissue regions in vivo which may be used herein with the devices and methods are shown and described in detail in U.S. Ser. No. 12/118,439 filed May 9, 2008, which is incorporated herein by reference in its entirety.
Aside from measuring anatomical features, another feature which physicians may utilize with the captured visual images of tissue may also include the monitoring of changes in color of a lesion formed over time. Tissue color may be used as a good indicator of the stage of completion of the lesion forming process as normal, unablated myocardial tissue is characteristically pink or red in color. During ablation the lesion site will change color due to heating, dessication, denaturation of proteins, and/or ischemia. The lesion site will typically become white and then possibly black, brown, or yellow as ablation continues if applied beyond the usual limits. During real-time visualization and ablation it may become difficult to distinguish the degree of color change that has taken place due to the graduated nature of the color change.
An example of monitoring color changes in tissue during ablation treatment is illustrated in FIG. 21A, which shows an overlay of multiple images of the tissue surface at preselected time intervals as ablation progresses from, e.g., 10 secs to 60 secs. The time intervals at which the captured images may be selected for viewing may be selected at relatively higher or lower sampling rates. As shown in this example, images of lesion 320 may be captured, e.g., at a recorded ablation time 340 of 10 sec, 30 sec, and 60 sec with a first corresponding image 342, second corresponding image 344, and third corresponding image 346 showing the progression of the tissue coloring from a pink or red state eventually to a blanched condition. Having these images simultaneously displayed may provide contextual information to the user in determining whether sufficient ablation had occurred in the tissue being treated.
Another variation is shown in FIG. 21B which illustrates monitor 278 showing a particular measured region 348 of lesion 320 tracked and imaged over a period of time from a first measured ablation time 352 to a final measured ablation time 354, e.g., from 10 sec to 60 sec. A temperature chart 350 may be provided illustrating the eventual change in tissue color as ablation progresses through the ablation treatment. One or more indicators may show the tissue coloring at a corresponding ablation time, e.g., from a first corresponding tissue image 356 to a final corresponding tissue image 358, which may be available to the user for assessment.
In monitoring the blanching of the tissue being treated during ablation, the degree of blanching may be determined by a number of different methods. Blanching occurs as a result of heating a tissue region which causes proteins to denature and desiccate. This eliminates blood flow from the tissue hence turning it from a pink or red color to a white color. Thus, blanching of tissue may serve as a visual indicator of ablated tissue. One example is shown in the flowchart 360 of FIG. 22 which illustrates how certain tissue characteristics may be monitored. Once the target tissue to be treated has been identified and the visualization and treatment catheter securely apposed against the tissue surface 362, ablation may be initiated 364 while under direct visualization through hood 12. A processor in communication with the imager may monitor a histogram of color channels of the tissue being visualized 366 and the processor may then determine a rate of change of the color histogram 368. If the rate of change is determined by the processor to be higher than a preset limit, this may be an indication that the tissue is blanching at a higher rate than desired and the processor may continue to monitor the tissue color change. Otherwise, if the rate of color change is lower than the preset limit, then the processor may determine the degree of surface reflectance 370. Again; if the processor indicates that the surface reflectance is higher than a preset value, then the color may continue to be monitored otherwise if the reflectance is lower than the preset value, a determination may be made as to whether there is any appearance of particular colors from the tissue which may indicate that ablation of the tissue is nearing completion, e.g., white, brown, yellow, black, etc. 372. If the processor does detect the appearance of any of these particular colors, an audible or visual indicator may notify the physician 374 and ablation may be stopped automatically by the processor or directly by the physician 376.
Additionally and/or alternatively, a processor may control the flow of the purging fluid which may also be used to conduct a current to the tissue to be treated. As illustrated in FIG. 23, flowchart 380 shows an example where the color change of the lesion may also be utilized for controlling or altering the purging fluid flow through the hood and over the tissue region being visualized and/or treated. It is generally desirable to deliver the lowest amount of saline to the patient through the hood 12 as an excessive flow of saline may cause the balance of electrolytes in the body to fluctuate potentially resulting in hyponatremia. Thus, once the hood 12 has been sufficiently apposed against the tissue surface, e.g., by utilizing ultrasound 382 as described above or through other methods, the saline fluid may be introduced into hood 12 to begin purging of the blood within the hood and to clear the visualization field 384. This fluid may be introduced at an initial predetermined rate and registering of the RGB ratio of the imaged underlying tissue may begin 386, as described above.
If the processor determines that the detected RGB color channels are increasing at a desirable preset rate in approaching a predefined boundary (utilizing parameters such as hue, saturation, etc.) 388, then the percentage of the color red may be determined for the captured image 392 and if the this percentage is above a predetermined level, then this is an indication that the visual field is sufficiently clearing of blood. However, if the RGB color channels are determined not to be increasing at a desirable rate, then the processor may automatically increase a flow rate 390 of the saline into the hood 12 to increase the rate at which blood is cleared. Likewise, if the percentage of the detected color red is found to be below the predetermined level, then monitoring of the color may be continued until the blood is sufficiently cleared from the visual field of hood 12.
Once the percentage of the detected color red is at a desired level, then the saline flow rate may be reduced to a predetermined level 394, e.g., defined by the physician or active recirculation of the saline may be produced within the hood. A determination may then be made as to whether to maintain the flow optimization 396 in which case if flow optimization is continued, then the color change within the hood may be continued to be monitored. Otherwise, the flow control may be terminated 398.
Yet another parameter utilizing the captured visual images during tissue ablation may include the detection of bubbles during ablation. The formation of bubbles may be visible on the monitor near or at the edges of the visual field and these bubbles may be generally indicative of high rates of heating, over-blanching of tissue, or a potential steam popping. FIG. 24 illustrates a flowchart 400 which shows one method for utilizing bubble detection where the process may begin 402 by acquiring the visual image 404, as previously described. The visual image may be processed by a processor to find locations of any “hotspots” 406, i.e., areas of high reflection, which may be indicative of the presence of bubbles. The visual field may then be searched for potentially spherical objects 408 and further monitored to determine whether a radius or diameter of any spherical objects are growing 410 during the ablation process. In the event that the detected radius is not any larger than a preset limit 412, then the process of searching may continue 414. Otherwise, if the radius is determined to exceed the preset limit, then the bubble diameter may continue to be monitored over time 416. The processor may then determine whether the number of detected bubbles in the visual field exceed a threshold value 418. In the event that the number of detected bubbles are insufficient, the physician may be notified and/or the power level may be maintained or increased 420 and the visual field may be continued to be monitored for the formation of bubbles. Otherwise, if the number of detected bubbles exceed the threshold number, then an alert may notify the physician and/or the system may power down automatically and/or the flow rate may be increased to cool the tissue region down in temperature 422.
The system then alerts the physician to take a measure of corrective actions which may include increasing the saline flow rate or powering down the system among other things. Bubbles may be difficult to detect with the naked eye, hence this protocol may be useful in alerting physicians immediately upon the presence of even tiny bubbles.
Additional methods and systems for bubble detection during tissue treatment are further described in detail in U.S. patent application Ser. No. 12/118,439 filed May 9, 2008, which has been incorporated herein by reference above.
The various protocols or methods disclosed may be used in any combination for processing the visual images generated. Additionally the overlays disclosed may be used in any combination as well to provide users with one or more layers of information.
In yet another example for processing captured visual images of tissue regions, FIGS. 25A and 25B illustrate side and plan views of a hood 12 which is placed into contact against a tissue region T to be visualized and/or treated. As the underlying tissue region moves such as during a cardiac or respiratory cycle, hood 12 may be inadvertently shifted from a first location 430 to a second location 432 over the tissue surface, as indicated respectively by two points labeled A and B. When such movement occurs, the region being visualized may move continually making it difficult to observe the tissue or to perform any procedures upon the tissue. Such movement can be monitored visually by several methods such that the user is able to determine an appropriate time to begin a procedure. The overlap region 434 may be calculated between the first location 430 and second location 432 compared against a threshold limit. With the distance of hood movement known, a procedure may be initiated and/or stopped appropriate each time the hood 12 is expected to move such that treatment may be synchronized according to hood and tissue movement.
In yet another example of utilizing the captured images, FIGS. 26A and 26B show side and monitor views of a hood 12 which is insufficiently apposed against the surface of a tissue region T to be visualized and/or treated. As it may be difficult to determine if the hood 12 is seated perpendicularly on the tissue surface or is in an off-axis configuration, it may be possible to detect and correct for such off-axis alignment from the tissue by processing of the visual images. If hood 12 is not placed into direct apposition against the tissue surface, gases introduced into hood 12 along with the purging fluid may form along the side of hood 12 which is not in contact with the tissue, i.e., bubbles 440 may form along a gap or spacing 442 between hood 12 and the tissue surface. These bubbles 440 may be visible in the field of view 282 and thus alert the user that the hood 12 positioning along the tissue may require readjustment.
US3162190 31 Oct 1962 22 Dic 1964 Del Gizzo Giovanni Diagnostic and exploratory instrument
US3452740 31 May 1966 1 Jul 1969 Us Catheter & Instr Corp Spring guide manipulator
US4717387 25 Jun 1986 5 Ene 1988 Sumitomo Electric Industries Ltd. Catheter
US5125895 19 Dic 1988 30 Jun 1992 Medtronic Versaflex, Inc. Steerable catheter
US5271383 5 Jun 1992 21 Dic 1993 Wilk Peter J Method for reducing intussusception
US5498239 17 Abr 1995 12 Mar 1996 Guided Medical Systems, Inc. Catheter placement by pressurizable tubular guiding core
US5857760 29 Nov 1995 12 Ene 1999 Lumatech Corporation Illuminated balloon apparatus and method
US5938586 1 May 1998 17 Ago 1999 Wilk & Nakao Medical Technology, Incorporated Endoscope biopsy channel liner and associated method
US6028622 23 Abr 1998 22 Feb 2000 Olympus Optical Co., Ltd. Observation apparatus for endoscopes
US6086557 1 Oct 1998 11 Jul 2000 Cardiothoracic Systems, Inc. Bifurcated venous cannula
US6458107 15 Nov 1999 1 Oct 2002 Daig Corporation Steerable coronary sinus catheter
US7860555 * 25 Oct 2005 28 Dic 2010 Voyage Medical, Inc. Tissue visualization and manipulation system
US20010007937 27 Feb 2001 12 Jul 2001 Mackin Robert A. Apparatus and method for contemporaneous treatment and fluoroscopic mapping of body tissue
US20040009155 12 Jul 2002 15 Ene 2004 Maria Palasis Method for sustaining direct cell delivery
US20040054724 1 Dic 2000 18 Mar 2004 Satoru Sudo Teleconferencing system
US20040210278 4 Dic 2003 21 Oct 2004 James Boll Esophageal treatment arrangement
US20040220470 3 Feb 2004 4 Nov 2004 The John Hopkins University Active MRI intramyocardial injection catheter with a deflectable distal section
US20060258909 * 7 Abr 2006 16 Nov 2006 Usgi Medical, Inc. Methods and apparatus for maintaining sterility during transluminal procedures
US20090187074 * 16 Ene 2009 23 Jul 2009 Nidus Medical, Llc Epicardial access and treatment systems
US20130172726 12 May 2010 4 Jul 2013 Voyage Medical, Inc. In-vivo visualization systems
EP0842673B1 6 Nov 1997 15 Ene 2003 Medtronic, Inc. Stabilized electrophysiology catheter and method for use
WO1997040880A1 14 Mar 1997 6 Nov 1997 Medtronic, Inc. Introducer system having kink resistant splittable sheath
WO2001072368B1 30 Mar 2001 26 Sep 2002 Medtronic Inc Intralumenal visualization system with deflectable mechanism
WO2002030310A9 1 Oct 2001 20 Feb 2003 Medtronic Inc Heart wall ablation/mapping catheter and method
WO2003039350A3 12 Nov 2002 19 Feb 2004 David Amundson Direct, real-time imaging guidance of cardiac catheterization
WO2005081202A8 17 Feb 2005 10 Nov 2005 Acumen Medical Inc Variable steerable catheters and methods for using them
WO2008015625A3 30 Jul 2007 5 Mar 2009 Alexander Fischer 3d segmentation by voxel classification based on intensity histogram thresholding initialised by k-means clustering
25 European Patent Application No. 08746822.9 filed Apr. 24, 2008 in the name of Rothe et al.. Office Action mailed Jul. 13, 2010.
35 * Saliba et al, Intracardiac echocardiography during catheter ablation of atrial fibrillation, Europace 2008, 10,i42-47.
Clasificación internacional A61B18/14, A61B1/05, A61B5/00, A61B5/113, A61B5/0472, A61B5/042
Clasificación cooperativa A61B5/0538, A61B5/0245, A61B5/0084, A61B1/05, A61B5/7285, A61B18/1492, A61B5/742, A61B5/6852, A61B5/01, A61B5/0452, A61B5/7289, A61B5/113, A61B5/0472, A61B5/042, A61B2218/002
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:MALCHANO, ZACHARY J.;PEH, RUEY-FENG;SAADAT, VAHID;AND OTHERS;SIGNING DATES FROM 20091218 TO 20100119;REEL/FRAME:023874/0844